Scioto Biosciences, Inc. — Form D
Scioto Biosciences, Inc. of INDIANOPOLIS, IN, a company, filed a Form D exempt-offering notice with the SEC on 2018-05-08. The offering totals $4.0M, of which $1.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-05-08
- Form: D
- Accession: 0001739633-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $1.8M
- Remaining: $2.2M
- Investors: 13
- Date of first sale: 2018-04-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-311852
Issuer
- Name: Scioto Biosciences, Inc.
- CIK: 0001739633
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: NOYES PAVILION 5TH FLOOR E504, INDIANOPOLIS, IN, 46202
- Phone: 317-652-1840
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| James Schulz | Director | New York, NY |
| Joseph Trebley | Director | Indianapolis, IN |
| Mark Heiman | Executive Officer | Indianapolis, IN |
| Kevin Meyer | Executive Officer | Indianapolis, IN |
| James Schulz | Executive Officer | New York, NY |
| Joseph Trebley | Executive Officer | Indianapolis, IN |
More